Epoch-cyclosporin A induces high response rates in relapsed lymphomas

作者: Tindara Panissidi , Amedea Donelli , Giuseppe Torelli , Caterina Chiodino

DOI:

关键词:

摘要:

参考文章(9)
Shigeru Tsukagoshi, Harumi Iida, Yoshio Sakurai, Makiko Nojiri, Takashi Tsuruo, Circumvention of Vincristine and Adriamycin Resistance in Vitro and in Vivo by Calcium Influx Blockers Cancer Research. ,vol. 43, pp. 2905- 2910 ,(1983)
W H Wilson, G Bryant, S Bates, A Fojo, R E Wittes, S M Steinberg, D R Kohler, E S Jaffe, J Herdt, B D Cheson, EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma. Journal of Clinical Oncology. ,vol. 11, pp. 1573- 1582 ,(1993) , 10.1200/JCO.1993.11.8.1573
B L Lum, S Kaubisch, A M Yahanda, K M Adler, L Jew, M N Ehsan, N A Brophy, J Halsey, M P Gosland, B I Sikic, Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance. Journal of Clinical Oncology. ,vol. 10, pp. 1635- 1642 ,(1992) , 10.1200/JCO.1992.10.10.1635
N L Bartlett, B L Lum, G A Fisher, N A Brophy, M N Ehsan, J Halsey, B I Sikic, Phase I trial of doxorubicin with cyclosporine as a modulator of multidrug resistance. Journal of Clinical Oncology. ,vol. 12, pp. 835- 842 ,(1994) , 10.1200/JCO.1994.12.4.835
A M Yahanda, K M Alder, G A Fisher, N A Brophy, J Halsey, R I Hardy, M P Gosland, B L Lum, B I Sikic, Phase I trial of etoposide with cyclosporine as a modulator of multidrug resistance. Journal of Clinical Oncology. ,vol. 10, pp. 1624- 1634 ,(1992) , 10.1200/JCO.1992.10.10.1624
Thierry Philip, Cesare Guglielmi, Anton Hagenbeek, Renier Somers, Hans Van Der Lelie, Dominique Bron, Pieter Sonneveld, Christian Gisselbrecht, Jean-Yves Cahn, Jean-Luc Harousseau, Bertrand Coiffier, Pierre Biron, Franco Mandelli, Franck Chauvin, Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma The New England Journal of Medicine. ,vol. 333, pp. 1540- 1545 ,(1995) , 10.1056/NEJM199512073332305
William S. Dalton, ALTERNATIVE (NON–P-GLYCOPROTEIN) MECHANISMS OF DRUG RESISTANCE IN NON-HODGKIN'S LYMPHOMA Hematology-oncology Clinics of North America. ,vol. 11, pp. 975- 986 ,(1997) , 10.1016/S0889-8588(05)70474-3